Abstract
The clinical relevance of multidrug resistance gene (mdr1) expression in tumor cells remains largely unclear. Conflicting results regarding mdr1 gene expression and clinical outcome have been obtained. Little is known about regulation of mdr1 gene expression, and the conflicting results might be explained by the fact that mdr1 RNA levels do not reflect expression at the protein level. The aim of the present study was to investigate the relationship between mdr1 RNA levels and P-glycoprotein (Pgp) content of leukemic cells from patients with acute myelogenous or lymphocytic leukemia. Mdr1 RNA levels were determined by a quantitative RNA-RNA solution hybridization method, and Pgp by Western blot technique with enhanced chemiluminescence for immunodetection. Pgp was detected in 14/14 leukemic cell samples while mdr1 RNA was detectable (>0.15 copies/cell) in cells from only six out of the 14 patients. Mdr1 RNA levels did not correlate with the Pgp content of leukemic cells (r=0.284,p=0.306). Relapsed leukemias had significantly (p=0.016) higher levels of Pgp thande novo untreated leukemias (the mean and SD optical density units were 0.56±0.18 and 0.25±0.17 respectively) while no difference was found in RNA levels. The findings support post-transcriptional level regulation of mdr1 gene expression and stress the importance of accurate determinations of the Pgp content of tumor cells in studies of the relationship between mdr1 gene expression and clinical outcome.
Similar content being viewed by others
References
McClean, S. and Hill, B.T. (1992) An overview of membrane, cytosolic and nuclear proteins associated with the expression of resistance to multiple drugsin vitro.Biochim. Biophys. Acta 1114, 107–27.
Pastan, I. and Gottesman, M.M. (1991) Multidrug resistance.Ann. Rev. Med. 42, 277–86.
Juliano, R. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants.Biochim. Biophys. Acta 455, 152–62.
Willingham, M.C., Cornwell, M.M., Cardarelli, C.O., Gottesman, M.M. and Pastan, I. (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.Cancer Res. 46, 5941–46.
Hamada, H. and Tsuruo, T. (1988) Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance: 170- to 180-kilodalton membrane glycoprotein is an ATPase.J. Biol. Chem. 263, 1454–8.
Gros, P., Croop, J. and Housman, D. (1986) Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.Cell 47, 371–80.
Gsur, A., Zöchbauer, S., Götzl, M., Kyrle, P.A., Lechner, K. and Pirker, R. (1993) MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update.Leuk Lymphoma 12, 91–4.
Paietta, E., Andersen, J., Racevskis, J., Gallagher, R., Bennett, J., Yunis, J., Cassileth, P. and Wiernik, P.H. (1994) Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: immunological, molecular and functional analyses.Leukemia 8, 968–73.
Nabors, M.W., Griffin, C.A., Zehnbauer, B.A., Hruban, R.H., Phillips, P.C., Grossman, S.A., Brem, H. and Colvin, O.M. (1991) Multidrug resistance gene (MDR1) expression in human brain tumors.J. Neurosurg. 75, 941–6.
Noonan, K.E., Beck, C., Holzmayer, T.A., Chin, J.E., Wunder, J.S., Andrulis, I.L., Gazdar, A.F., Willman, C.L., Griffith, B., Von Hoff, D. and Roninson, I.B. (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.Proc. Natl. Acad. Sci. USA 87, 7160–64.
Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues.Proc. Natl. Acad. Sci. USA 84, 265–9.
Sato, H., Preisler, H., Day, R., Raza, A., Larson, R., Browman, G., Goldberg, J., Vogler, R., Grunwald, H., Gottlieb, A., Bennett, J., Gottesman, M. and Pastan, I. (1990) MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.Br. J. Haematol. 75, 340–5.
Marie, J.P., Zittoun, R. and Sikic, B.I. (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome andin vitro drug sensitivity.Blood 78, 586–92.
Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O.A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H. and Lechner, K. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia.J. Natl. Cancer Inst. 83, 708–12.
Gruber, A., Vitols, S., Norgren, S., Areström, I., Peterson, C., Björkholm, M., Reizenstein, P. and Luthman, H. (1992) Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.Br. J. Cancer 66, 266–72.
Zöchbauer, S., Gsur, A., Brunner, R., Kyrle, P.A., Lechner, K. and Pirker, R. (1994) P-glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia.Leukemia 8, 974–7.
Lepelley, P., Soenen, V., Preudhomme, C., Lai, J.L., Cosson, A. and Fenaux, P. (1994) Expression of the multidrug resistance P-glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes.Leukemia 8, 998–1004.
Cordon-Cardo, C., O’Brien, J.P., Boccia, J., Casals, D., Bertino, J.R. and Melamed, M.R. (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.J. Histochem. Cytochem. 38, 1277–87.
Kuwazuru, Y., Yoshimura, A., Hanada, S., Utsunomiya, A., Makino, T., Ishibashi, K., Kodama, M., Iwahashi, M., Arima, T. and Akiyama, S. (1990) Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.Cancer 66, 868–73.
Campos, L., Guyotat, D., Jaffar, C., Solary, E., Archimbaud, E. and Treille, D. (1992) Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia.Eur. J. Haematol. 48, 254–8.
Wittebol, S., Te Boekhorst, P., Hagemeijer, A., Van Dongen, J.J.M., Schoester, M. and Sonneveld, P. (1992) Expression of the multidrug resistance (mdr-1) phenotype in acute myelocytic leukemia is associated with CD34 expression and monosomy 7 and predicts for poor survival.Blood 80, Suppl 1:202a.
Zhou, D.C., Marie, J.P., Suberville, A.M. and Zittoun, R. (1992) Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.Leukemia 6, 879–85.
Willman, C.L., Kopecky, K.J., Weick, J., Appelbaum, F., Grever, M.R., Head, D.R., Elias, L., Balcerzak, S.P., Mills, G.M. and Hynes, H.E. (1992) Biologic parameters that predict treatment response inde novo acute myeloid leukemia (AML): CD34, but not multidrug resistance (MDR) gene expression, is associated with a decreased complete remission (CR) rate and CD34+ patients more frequently achieve CR with high dose cytosine arabinoside.Proc. ASCO 11, 262.
Sugawara, I., Koji, T., Ueda, K., Pastan, I., Gottesman, M.M., Nakane, P.K. and Mori, S. (1990)In situ localization of the human multidrug-resistance gene mRNA using thymine-thymine dimerized single-stranded cDNA.Jpn J. Cancer Res. 81, 949–55.
Hegewisch-Becker, S., Fliegner, M., Tsuruo, T., Zander, A., Zeller, W. and Hossfeld, D.K. (1993) P-glycoprotein expression in normal and reactive bone marrows.Br. J. Cancer 67, 430–5.
Kakehi, Y., Kanamaru, H., Yoshida, O., Ohkubo, H., Nakanishi, S., Gottesman, M.M. and Pastan, I. (1988) Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.J. Urol. 139, 862–5.
Mizoguchi, T., Yamada, K., Furukawa, T., Hidaka, K., Hisatsugu, T., Shimazu, H., Tsuruo, T., Sumizawa, T. and Akiyama, S. (1990) Expression of the MDR1 gene in human gastric and colorectal carcinomas.J. Natl. Cancer Inst. 82, 1679–83.
Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D. and Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis.Blood 79, 473–6.
Shen, D.W., Fojo, A., Chin, J.E., Roninson, I.B., Richert, N., Pastan, I. and Gottesman, M.M. (1986) Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.Proc. Natl. Acad. Sci. USA 83, 4538–42.
Scheper, R.J., Bulte, J.W.M., Brakkee, J.G.P., Quak, J.J., Van der Schoot, E., Balm, A.J.M., Meijer, C.J., Broxterman, H.J., Kuiper, C.M., Lankelma, J. and Pinedo, H.M. (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance.Int. J. Cancer 42, 389–94.
Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.Br. J. Haematol. 33, 451–8.
Ueda, K., Clark, D.P., Chen, C.J., Roninson, I.B., Gottesman, M.M. and Pastan, I. (1987) The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.J. Biol. Chem. 262, 505–8.
Labarca, C. and Paigen, K. (1980) A simple, rapid, and sensitive DNA assay procedure.Anal Biochem. 102, 344–52.
Lowry, U.H., Rosenbrough, N.J., Farr, A.I. and Randall, R.L. (1951). Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193, 265–75.
Laemmili, U.K. (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4.Nature 227, 247–54.
Bates, S.E., Mickley, L.A., Chen, Y.N., Richert, N., Rudick, J., Biedler, J.L. and Fojo, A.T. (1989) Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.Mol. Cell. Biol. 9, 4337–44.
Marino, P.A., Gottesman, M.M. and Pastan, I. (1990) Regulation of the multidrug resistance gene in regenerating rat liver.Cell Growth Differ. 1, 57–62.
Chin, K.V., Tanaka, S., Darlington, G., Pastan, I. and Gottesman, M.M. (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells.J. Biol. Chem. 265, 221–6.
Hill, B.T., Deuchars, K., Hosking, L.K., Ling, V. and Whelan, R.D. (1990) Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiationin vitro.J. Natl. Cancer Inst. 82, 607–12.
McClean, S. and Hill, B.T. (1993) Post-translational regulation of P-glycoprotein in mammalian tumour cells expressing a distinctive multiple drug resistant phenotype after exposure to fractionated X — irradiation.Proc. AACR 34, 313.
Bradley, G., Naik, M. and Ling, V. (1989) P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines.Cancer Res. 49, 2790–6.
Chen, Y.F., Murawski, M.J., Fredericks, W.J., Karakousis, C. and Baker R.M. (1990) Comparison of Western blot and RNA slot blot detection of mdr1 gene expression in human tumors.Proc. AACR 31, 537.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albertioni, F., Gruber, A., Areström, I. et al. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia. Med Oncol 12, 79–86 (1995). https://doi.org/10.1007/BF01676707
Issue Date:
DOI: https://doi.org/10.1007/BF01676707